Adults with lung, breast, or ovarian/fallopian tube cancers invited to be in a nerve disorder research study.

UVA Tracking #
HSR200018
Principal Investigator
Linda R Duska
Contact
Anne Gabel
Contact Email
Contact Phone
434.982.6657
Official Trial Title
PROSPECTIVE OBSERVATIONAL COHORT STUDY TO DEVELOP A PREDICTIVE MODEL OF TAXANE-INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS
Study Description

The University of Virginia is conducting a clinical research study for adults ages 18 and over, who have non-small cell lung cancer (NSCLC), breast cancer or primary ovarian/fallopian tube cancer. The purpose of this study is to try to learn how certain risk factors, such as age, gender, pre-existing conditions, the type of treatment you get for your cancer, and the amount of cancer drugs in your body affect whether you develop the nerve disorder and how bad your symptoms will be.

Participation is approximately 10 visits over the course of 3 years. This study involves standard chemotherapy treatment as well as additional blood draws and questionnaires, each visit lasting 2-4 hours.

Study-related procedures that are being done beyond your standard of care will be provided at no cost to your or your insurance.

Additional information can be found here: https://clinicaltrials.gov/ct2/show/NCT03939481

Compensation

N/A